EMA Greenlights Four New Therapies Including Deqsiga for Immune Disorders 12 months ago ByJohnIn Breaking NewsLeaders
Sanofi and Teva Unveil Strong Phase 2b Data for Duvakitug, Offering New Hope for IBD Patients 12 months ago ByJohnIn BreakthroughsClinical Trials
Roche Unveils Breakthrough Sequencing by Expansion Technology That Could Transform Clinical Genomics 12 months ago ByJohnIn Biopharma HighlightsResearch Updates
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships 12 months ago ByJohnIn DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences 12 months ago ByJohnIn AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Clinical Trial Supply Europe 2025: AI, Supply Chain Resilience and Trial Operations Take Center Stage 12 months ago ByJohnIn Industry ConferencesLeadersPeople
FDA Greenlights Merilog—the First Insulin Aspart Biosimilar—Boosting Access and Competition in Diabetes Care 12 months ago ByJohnIn Breaking NewsClinical TrialsFDA Approvals
FDA Approves Vimseltinib (Romvimza) for Tenosynovial Giant Cell Tumor—A Targeted Therapy First 12 months ago ByJohnIn Biopharma HighlightsBreakthroughsFDA Approvals
FDA Clears Innovative SPN-830 Apomorphine Infusion System for Advanced Parkinson’s Disease 12 months ago ByJohnIn FDA ApprovalsInnovationTechnology
FDA Clears First-ever Pentavalent Meningococcal Vaccine—A New Era in Preventing Invasive Meningococcal Disease 12 months ago ByJohnIn DealsFDA ApprovalsPharma Industry Updates
UK Advances Clinical Trial Landscape: Historic Regulation Reform Paves Way for Efficiency and Inclusivity 12 months ago ByJohnIn BreakthroughsClinical Trials
Final Analysis of TROPION-Breast01 Reveals No Overall Survival Benefit for Dato-DXd in HR+/HER2– Breast Cancer, Despite PFS Gains 12 months ago ByJohnIn Research UpdatesTop Stories
India Poised to Become Major Hub for Early-Stage Clinical Trials Amid Global Shifts 12 months ago ByJohnIn Breaking NewsClinical Trials
Grace Therapeutics’ GTx-104 IV Nimodipine Formulation Reduces Hypotension and ICU Burden in Aneurysmal Subarachnoid Hemorrhage Phase III Trial 1 year ago ByJohnIn Biopharma HighlightsBreaking NewsTop Stories
